Abstract
Introduction: In the last decades, many medications have been tested for the treatment of Alcohol Use Disorder (AUD). Among them, disulfiram, acamprosate, naltrexone, nalmefene, sodium oxybate and baclofen have been approved in different countries, with different specific indications. Topiramate is not approved for the treatment of AUD, however, it is suggested as a therapeutic option by the American Psychiatric Association for patients who do not tolerate or respond to approved therapies.Areas covered: In this narrative review we have analyzed the main studies available in literature, investigating the efficacy and safety of these medications, distinguishing whether they were oriented towards abstinence or not. Randomized controlled studies, analyzing larger populations for longer periods were the main focus of our analysis.Conclusions: The medications currently available for the treatment of AUD are quite effective, yet further progress can still be achieved through the personalized strategies. Also, these medications are still markedly underutilized in clinical practice and many patients do not have access to specialized treatment.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 13-22 |
| Numero di pagine | 10 |
| Rivista | European Journal of Internal Medicine |
| Volume | 103 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2022 |
OSS delle Nazioni Unite
Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile
-
SDG 3 Salute e benessere
Keywords
- Acamprosate
- Alcohol use disorder
- Baclofen
- Disulfiram
- Topiramate
- Naltrexone
- Number needed to treat (NNT)
- Pharmacological treatment
- Nalmefene
Fingerprint
Entra nei temi di ricerca di 'Perspectives on the pharmacological management of alcohol use disorder: Are the approved medications effective?'. Insieme formano una fingerprint unica.Cita questo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver